Jazz Pharmaceuticals (NASDAQ:JAZZ): Insights on Analyst Ratings

Monday, 9 September 2024, 11:01
Jazz Pharmaceuticals is under the spotlight as analysts provide insights into 12 ratings and price targets. The average target stands at $164.5, with estimates ranging from $113 to $210. Discover the implications of these ratings for investors.
Benzinga
Jazz Pharmaceuticals (NASDAQ:JAZZ): Insights on Analyst Ratings

Evaluate Analyst Ratings for Jazz Pharmaceuticals

Investors and stakeholders should pay attention to recent evaluations of Jazz Pharmaceuticals. Analysts have shared their insights, highlighting a variety of ratings and price targets.

Analyst Insights

  • Average Target Price: $164.5
  • High Estimate: $210.00
  • Low Estimate: $113.00

These ratings suggest potential volatility ahead. Understanding analysts' perspectives can inform investment strategies moving forward.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe